Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 4/2011

01-08-2011 | Letter to the Editor

Comment on “Incidental focal hypermetabolic colorectal lesions identified by positron emission tomography: prevalence of malignancy”

Author: Giorgio Treglia

Published in: Abdominal Radiology | Issue 4/2011

Login to get access

Excerpt

I have read with attention the article of Philip Shie recently published in this journal [1]. …
Literature
1.
Shie P (2011) Incidental focal hypermetabolic colorectal lesions identified by positron emission tomography: prevalence of malignancy. Abdom Imaging 36(2):165–169PubMedCrossRef
2.
Pandit-Taskar N, Schöder H, Gonen M, Larson SM, Yeung HW (2004) Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. AJR 183:1143–1147PubMed
3.
Wang G, Lau EW, Shakher R, et al. (2007) How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT? Cancer 109:117–124PubMedCrossRef
4.
Tessonnier L, Gonfrier S, Carrier P, et al. (2008) Unexpected focal bowel 18-FDG uptake sites: should they be systematically investigated? Bull Cancer 95:1083–1087PubMed
5.
Lee ST, Tan T, Poon AM, et al. (2008) Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-d-glucose-avid colon lesions. Mol Imaging Biol 10:48–53PubMedCrossRef
6.
Lee JC, Hartnett GF, Hughes BG, Ravi Kumar AS (2009) The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT. Nucl Med Commun 30:333–337PubMedCrossRef
7.
Ozkol V, Alper E, Aydin N, et al. (2010) The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography. Nucl Med Commun 31:128–136PubMedCrossRef
8.
Luboldt W, Volker T, Wiedemann B, et al. (2010) Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off. Eur Radiol 20:2274–2285PubMedCrossRef
9.
Kei PL, Vikram R, Yeung HW, Stroehlein JR, Macapinlac HA (2010) Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results. AJR 194:W401–W406PubMedCrossRef
10.
Xu H, Zhang M, Zhai G, Li B (2010) The clinical significance of 18F-FDG-PET/CT in early detection of second primary malignancy in cancer patients. J Cancer Res Clin Oncol 136:1125–1134PubMedCrossRef
Metadata
Title
Comment on “Incidental focal hypermetabolic colorectal lesions identified by positron emission tomography: prevalence of malignancy”
Author
Giorgio Treglia
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 4/2011
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9747-4

Other articles of this Issue 4/2011

Abdominal Radiology 4/2011 Go to the issue

OriginalPaper

Internal hernias after abdominal surgeries: MDCT features

OriginalPaper

Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)

OriginalPaper

Morphology of intraductal papillary neoplasm of the bile ducts: radiologic–pathologic correlation

Pictorial essay

Intestinal and multivisceral transplantation

OriginalPaper

Intrabiliary rupture of hepatic hydatid cyst: multidetector-row CT demonstration

OriginalPaper

Laparoscopic sleeve gastrectomy: a guide to postoperative anatomy and complications
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits